LEO PHARMA A/S: Financial statements 2016
CVR: 56759514
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 7,360,000,000 and a net result of DKK 743,000,000 compared with DKK 645,000,000 the year before. That is an increase of 7% compared with the year before. The profit margin was 10.1%. Equity in the 2016 report amounted to DKK 25,212,000,000. The solvency ratio was 66.6%. The company had 5,170 employees in the financial year.
- Revenue
- DKK 7,360,000,000
- Gross Profit
- DKK 2,716,000,000
- Profit/Loss
- DKK 743,000,000
- Equity
- DKK 25,212,000,000
- Total Assets
- DKK 37,831,000,000
- Employees
- 5,170
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 7.4 mia. | 2.7 mia. | 743 mio. | 25.2 mia. | 5170 |
| 2015 | 6.9 mia. | 2 mia. | 645 mio. | 25.3 mia. | 4813 |
| 2014 | 6.6 mia. | - | 1.5 mia. | 24.5 mia. | 4712 |
| 2013 | 5.8 mia. | - | 1.2 mia. | 23.1 mia. | 4733 |
Official annual report
Find more companies like LEO PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of December 9, 2016, Jan Rasmussen has joined the board of directors of LEO PHARMA A/S.
As of December 9, 2016, Morten Drewes Pedersen has left the board of directors of LEO PHARMA A/S.
As of June 24, 2016, Jesper Høiland has joined the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2015. Revenue came to DKK 6,876,000,000, and the net result was DKK 645,000,000.
As of January 1, 2016, Jukka Pekka Pertola has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2016, Patrik Olof Dahlén has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2016, Poul Rødbroe Rasmussen has left the board of directors of LEO PHARMA A/S.
About LEO PHARMA A/S
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Christophe Dominique Luc Charles Bourdon and Philip Harald Eickhoff. The board consists of Jesper Brandgaard (chair), Paul Olivier Marie Navarre, Peter Helt Jacobsen Haahr and Aino Anna Liisa Hurme. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 1,047 employees (2026). In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity in the 2025 report amounted to DKK 5,262,000,000.